Thank you
This live web event has ended. Thank you for attending.
This live web event has ended. Thank you for attending.
Kelly Colletti obtained her Ph.D. in
Cellular and Molecular Biology as well as her MBA at the University of Nevada,
Reno in 2005. Kelly joined Charles River in early 2009 and is currently the
Scientific Director of Bioanalytical and Molecular Biology and manages a team
of 12 scientists. She has developed and validated hundreds of bioanalytical
methods including nonclinical and clinical bioanalytical, immunogenicity, nAb,
qPCR, and biomarker assays in her time with Charles River and has supported
several BLA filings. She has substantial expertise in the area of regulated
bioanalysis of biotherapeutics as well as gene and cell therapy products